Logo image of S

SENTINELONE INC -CLASS A (S) Stock Fundamental Analysis

USA - NYSE:S - US81730H1095 - Common Stock

16.68 USD
-0.14 (-0.83%)
Last: 10/17/2025, 7:00:00 PM
16.72 USD
+0.04 (+0.24%)
After Hours: 10/17/2025, 7:00:00 PM
Fundamental Rating

4

Overall S gets a fundamental rating of 4 out of 10. We evaluated S against 282 industry peers in the Software industry. While S seems to be doing ok healthwise, there are quite some concerns on its profitability. S is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

S had positive earnings in the past year.
S had a positive operating cash flow in the past year.
In the past 5 years S always reported negative net income.
S had negative operating cash flow in 4 of the past 5 years.
S Yearly Net Income VS EBIT VS OCF VS FCFS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B -10B

1.2 Ratios

S's Return On Assets of -18.27% is on the low side compared to the rest of the industry. S is outperformed by 70.57% of its industry peers.
With a Return On Equity value of -28.48%, S is not doing good in the industry: 60.64% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -18.27%
ROE -28.48%
ROIC N/A
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
S Yearly ROA, ROE, ROICS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

The Gross Margin of S (74.95%) is better than 65.96% of its industry peers.
In the last couple of years the Gross Margin of S has grown nicely.
The Profit Margin and Operating Margin are not available for S so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
S Yearly Profit, Operating, Gross MarginsS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

S does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for S has been increased compared to 1 year ago.
The number of shares outstanding for S has been increased compared to 5 years ago.
There is no outstanding debt for S. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
S Yearly Shares OutstandingS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
S Yearly Total Debt VS Total AssetsS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

S has an Altman-Z score of 3.06. This indicates that S is financially healthy and has little risk of bankruptcy at the moment.
S has a Altman-Z score (3.06) which is comparable to the rest of the industry.
S has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.06
ROIC/WACCN/A
WACC11.19%
S Yearly LT Debt VS Equity VS FCFS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B 30B

2.3 Liquidity

A Current Ratio of 1.83 indicates that S should not have too much problems paying its short term obligations.
S has a Current ratio of 1.83. This is comparable to the rest of the industry: S outperforms 57.80% of its industry peers.
S has a Quick Ratio of 1.83. This is a normal value and indicates that S is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.83, S is in line with its industry, outperforming 58.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
S Yearly Current Assets VS Current LiabilitesS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 350.00% over the past year.
S shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.39%.
The Revenue has been growing by 77.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)25.39%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%21.74%

3.2 Future

S is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 84.57% yearly.
S is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.16% yearly.
EPS Next Y281.83%
EPS Next 2Y157.72%
EPS Next 3Y111.31%
EPS Next 5Y84.57%
Revenue Next Year22.3%
Revenue Next 2Y21.43%
Revenue Next 3Y20.43%
Revenue Next 5Y22.16%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
S Yearly Revenue VS EstimatesS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
S Yearly EPS VS EstimatesS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

S is valuated quite expensively with a Price/Earnings ratio of 166.80.
S's Price/Earnings ratio is in line with the industry average.
S is valuated expensively when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 50.23, which means the current valuation is very expensive for S.
The rest of the industry has a similar Price/Forward Earnings ratio as S.
The average S&P500 Price/Forward Earnings ratio is at 22.94. S is valued rather expensively when compared to this.
Industry RankSector Rank
PE 166.8
Fwd PE 50.23
S Price Earnings VS Forward Price EarningsS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as S.
Industry RankSector Rank
P/FCF 336.75
EV/EBITDA N/A
S Per share dataS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as S's earnings are expected to grow with 111.31% in the coming years.
PEG (NY)0.59
PEG (5Y)N/A
EPS Next 2Y157.72%
EPS Next 3Y111.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for S!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENTINELONE INC -CLASS A

NYSE:S (10/17/2025, 7:00:00 PM)

After market: 16.72 +0.04 (+0.24%)

16.68

-0.14 (-0.83%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-28 2025-08-28/amc
Earnings (Next)12-02 2025-12-02/amc
Inst Owners82.27%
Inst Owner Change0.04%
Ins Owners0.53%
Ins Owner Change3.95%
Market Cap5.59B
Analysts78.18
Price Target24.19 (45.02%)
Short Float %4.68%
Short Ratio1.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.04%
Min EPS beat(2)23.01%
Max EPS beat(2)37.07%
EPS beat(4)3
Avg EPS beat(4)33.72%
Min EPS beat(4)-100%
Max EPS beat(4)174.81%
EPS beat(8)7
Avg EPS beat(8)85.06%
EPS beat(12)11
Avg EPS beat(12)65.32%
EPS beat(16)15
Avg EPS beat(16)53.02%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-1.95%
Max Revenue beat(2)-1.67%
Revenue beat(4)0
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-1.95%
Max Revenue beat(4)-0.52%
Revenue beat(8)3
Avg Revenue beat(8)-0.28%
Revenue beat(12)5
Avg Revenue beat(12)-0.13%
Revenue beat(16)9
Avg Revenue beat(16)1.44%
PT rev (1m)0.3%
PT rev (3m)2.93%
EPS NQ rev (1m)0.06%
EPS NQ rev (3m)-7.44%
EPS NY rev (1m)-4.82%
EPS NY rev (3m)-4.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.28%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 166.8
Fwd PE 50.23
P/S 6.16
P/FCF 336.75
P/OCF 137.51
P/B 3.71
P/tB 7.13
EV/EBITDA N/A
EPS(TTM)0.1
EY0.6%
EPS(NY)0.33
Fwd EY1.99%
FCF(TTM)0.05
FCFY0.3%
OCF(TTM)0.12
OCFY0.73%
SpS2.71
BVpS4.5
TBVpS2.34
PEG (NY)0.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.27%
ROE -28.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.95%
FCFM 1.83%
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 53.73%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 3.06
F-Score6
WACC11.19%
ROIC/WACCN/A
Cap/Depr(3y)58.32%
Cap/Depr(5y)105.17%
Cap/Sales(3y)3.59%
Cap/Sales(5y)4.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y281.83%
EPS Next 2Y157.72%
EPS Next 3Y111.31%
EPS Next 5Y84.57%
Revenue 1Y (TTM)25.39%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%21.74%
Revenue Next Year22.3%
Revenue Next 2Y21.43%
Revenue Next 3Y20.43%
Revenue Next 5Y22.16%
EBIT growth 1Y-2.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year315.2%
EBIT Next 3Y92.41%
EBIT Next 5Y62.03%
FCF growth 1Y112.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.39%
OCF growth 3YN/A
OCF growth 5YN/A